CTRI/2022/04/041870进行中（未招募）4 期
Phase IV study to assess the safety and effectiveness ofDienogest (Visanne®) amongst Indian women withEndometriosis, in real-world clinical practice: the VISAGEStudy - VISAGE
试验速览
- 阶段
- 4 期
- 状态
- 进行中（未招募）
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Observational
入排标准
入选标准
- •Female patients in India at least 18 years of age
- •Clinical or surgical diagnosis of endometriosis: Clinical diagnosis by suggestive symptoms
- •and positive finding in imaging study (Chocolate cyst)
- •Patients diagnosed with endometriosis associated pelvic pain who have not been previously
- •treated with Dienogest
- •Decision to initiate treatment with Dienogest was made as per investigator’s routine
- •treatment practice
- •Signed informed consent
排除标准
- •Participation in an investigational program with interventions outside of routine clinical
- •Contra-indications according to the local summary of product characteristics (SPC)
研究者
相似试验
进行中（未招募）
1 期
Study to assess the efficacy and safety of a basal insulin (Glargine 300) on glycemic control type 2 diabetic patients during hospitalization and at discharge.MedDRA version: 18.1Level: LLTClassification code 10049746Term: Insulin-requiring type II diabetes mellitusSystem Organ Class: 100000004861Type 2 DiabetesEUCTR2015-004715-20-ESSANOFI-AVENTIS, S.A.106
进行中（未招募）
4 期
To compare combination of study with marketed other combination of drug in patients having both anxiety and depression.CTRI/2022/11/047050Mankind Pharma Limited
招募中
不适用
A Clinical Study to Evaluate Efficacy and Safety of Imatinib (Glinib®) in Pateitns with LeukiemiaDiseases of the blood and blood -forming organs and certain disorders involving the immune mechanismKCT0002068Dong-A ST150
已完成
4 期
To collect the safety and efficacy data in patients with metastatic colorectalcancer after giving regorafenib in Indianpatients.CTRI/2018/06/014371Bayer AG100
进行中（未招募）
4 期
To assess safety and effectiveness of Rivaroxaban(Xarelto)in managing coronary and or symptomatic peripheral artery disease in Indian PatientsCTRI/2022/01/039597Bayer Zydus Pharma Pvt Ltd